CAL
BIVV

Capital Advisors Ltd’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Capital Advisors Ltd’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8
Closed – – 405
2017
Q4 		$0 Hold
8
– – ﹤0.01% 413
2017
Q3 		$0 Hold
8
– – ﹤0.01% 414
2017
Q2 		$0 Hold
8
– – ﹤0.01% 410
2017
Q1 		$0 Buy
+8
New +$394 ﹤0.01% 403

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Capital Advisors Ltd's BIVV Position: Q1 2018 in Review

Capital Advisors Ltd sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 8 shares.

Capital Advisors Ltd first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $0 in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Capital Advisors Ltd reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Capital Advisors Ltd sold 8 Bioverativ Inc. Common Stock shares in Q1 2018.
  • Capital Advisors Ltd first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Capital Advisors Ltd's Bioverativ Inc. Common Stock position peaked at $0 in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Capital Advisors Ltd's 13F filing for Q1 2018, filed 23 Apr 2018.